{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lenexa",
      "state": "KS",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "80813",
      "recalling_firm": "Remel Inc",
      "address_1": "12076 Santa Fe Trail Dr",
      "address_2": "N/A",
      "postal_code": "66215-3519",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US, Canada, Singapore",
      "recall_number": "Z-3019-2018",
      "product_description": "remel THIOGLYCOLLATE MEDIUM, REF 05152",
      "product_quantity": "48 units",
      "reason_for_recall": "Products have intermittently failed performance testing during stability studies with various anaerobic microorganisms.",
      "recall_initiation_date": "20180813",
      "center_classification_date": "20180907",
      "termination_date": "20190618",
      "report_date": "20180919",
      "code_info": "Lot number: 258192"
    }
  ]
}